HOLX 241115 82.50P (HOLX241115P82500) Stock Options, News & Quotes

4.00
+0.20+5.26%

15min DelayClose Nov 14 16:00 ET

4.00High4.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Trytosaveabit

Apr 11 13:11

Update

$Hologic (HOLX.US)$ Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography 3 MINUTES AGO, 2:07 PM EDT VIA BUSINESSWIRE Collaboration Includes Robust Education and Training to Support Radiologists and Imaging Specialists Bayer and Hologic, Inc. (NASDAQ:HOLX) today announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The two ...

Moomoo AI

Feb 12 09:38

Multiple insiders selling shares could be a red flag. The absence of insider purchases and significant selling over the last three months may suggest insiders believe the shares are overpriced. Despite high insider ownership, the lack of buying and significant selling raises concerns about the company.

Possible Bearish Signals With Hologic Insiders Disposing Stock

Moomoo AI

Nov 21, 2023 06:16

Undervalued Hologic presents opportunity to accumulate stocks. Investors cautioned to consider financial health. Company's outlook suggests further growth not reflected in share price.

Is Now An Opportune Moment To Examine Hologic, Inc. (NASDAQ:HOLX)?

FrankieSmilez

May 10, 2023 13:10

$Teva Pharmaceutical Industries (TEVA.US)$ $Church & Dwight (CHD.US)$ $Hologic (HOLX.US)$ $Dare Bioscience (DARE.US)$ $Femasys (FEMY.US)$ $Pfizer (PFE.US)$ Breaking News

Movers and Shakers

Jan 9, 2023 07:48

Columns Today's Pre-Market Stock Movers: LULU, TSLA, BBBY, Z and More

Gapping up
$Visa (V.US)$ +1.1%, $MasterCard (MA.US)$ +1.7% (Keybanc upgraded their ratings to overweight from from sector weight.)
$Zillow-C (Z.US)$ +4% (Bank of America double upgraded the stock to buy, citing its improved growth outlook despite a challenging macroeconomic environment.)
$Hologic (HOLX.US)$ +2.8% (The women's diagnostics provider reported fiscal first quarter revenue Sunday that topped its most recent guidance and Wall Str...